Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Public ClinicalTrials.gov record NCT07697456. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Study identification
- NCT ID
- NCT07697456
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 2,000 participants
Conditions and interventions
Conditions
Interventions
- Risankizumab Drug
- Trosunilimab Drug
- ABBV-701 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 23, 2026
- Primary completion
- Sep 30, 2031
- Completion
- Sep 30, 2031
- Last update posted
- Jul 12, 2026
2026 – 2031
United States locations
- U.S. sites
- 9
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Auzmer Research /ID# 280786 | Lakeland | Florida | 33813 | — |
| Gastro Health - Miami /ID# 282001 | Miami | Florida | 33176 | — |
| Portland Gastroenterology Center - Portland - Congress Street /ID# 281970 | Portland | Maine | 04102 | — |
| Hackensack Meridian Health - Hackensack University Medical Center /ID# 281865 | Hackensack | New Jersey | 07601 | — |
| Queens Village Primary Medical Center /ID# 281857 | New York | New York | 11428 | — |
| Digestive Disease Consultants - Brunswick /ID# 283935 | Brunswick | Ohio | 44212 | — |
| Skyline Gastroenterology of West Tennessee /ID# 284146 | Jackson | Tennessee | 38301 | — |
| Texas Digestive Disease Consultants /ID# 284159 | Austin | Texas | 78731 | — |
| Gi Alliance - Texas Digestive Disease Consultants - San Marcos /ID# 283947 | San Marcos | Texas | 78666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07697456, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07697456 live on ClinicalTrials.gov.